<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36575228</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1348-4214</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Hypertension research : official journal of the Japanese Society of Hypertension</Title><ISOAbbreviation>Hypertens Res</ISOAbbreviation></Journal><ArticleTitle>Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>619</EndPage><MedlinePgn>601-619</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41440-022-01145-2</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) affects infected patients even after the acute phase and impairs their health and quality of life by causing a wide variety of symptoms, referred to as long COVID. Although the evidence is still insufficient, hypertension is suspected to be a potential risk factor for long COVID, and the occurrence of cardiovascular diseases seems to be a key facet of multiple conditions observed in long COVID. Nonetheless, there are few reports that comprehensively review the impacts of long COVID on hypertension and related disorders. As a sequel to our previous report in 2020 which reviewed the association of COVID-19 and hypertension, we summarize the possible influences of long COVID on hypertension-related organs, including the cardiovascular system, kidney, and endocrine system, as well as the pathophysiological mechanisms associated with the disorders in this review. Given that the clinical course of COVID-19 is highly affected by age and sex, we also review the impacts of these factors on long COVID. Lastly, we discuss areas of uncertainty and future directions, which may lead to better understanding and improved prognosis of clinical problems associated with COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Chisa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Preventive medicine, Tokyo Medical University, Tokyo, Japan. chisa-ma@tokyo-med.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Shigeru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. shigeru.shibata@med.teikyo-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishi</LastName><ForeName>Takuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare, Okawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mogi</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Geriatric and General Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Kazuo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kobayashi Internal Medicine Clinic, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Masami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Adachi Medical Center, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asayama</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Eiichiro</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagami</LastName><ForeName>Hironori</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Development and Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshide</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukoyama</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kario</LastName><ForeName>Kazuomi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Node</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Saga University, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rakugi</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Geriatric and General Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hypertens Res</MedlineTA><NlmUniqueID>9307690</NlmUniqueID><ISSNLinking>0916-9636</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3</RefSource><PMID Version="1">35132265</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Endocrine</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Kidney</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Sex difference</Keyword></KeywordList><CoiStatement>The Department of Health Development and Medicine in Osaka University is an endowed department supported by Anges, Daicel, and FunPep. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36575228</ArticleId><ArticleId IdType="pmc">PMC9793823</ArticleId><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pii">10.1038/s41440-022-01145-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). COVID-19 Dashboard. https://coronavirus.jhu.edu/map.html.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res. 2020;43:1028&#x2013;46. doi: 10.1038/s41440-020-0515-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0515-0</ArticleId><ArticleId IdType="pmc">PMC7393334</ArticleId><ArticleId IdType="pubmed">32737423</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells. 2020;9:2508.. doi: 10.3390/cells9112508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112508</ArticleId><ArticleId IdType="pmc">PMC7699571</ArticleId><ArticleId IdType="pubmed">33228225</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;95 e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, et al. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens Res. 2022:1&#x2013;12. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780104</ArticleId><ArticleId IdType="pubmed">36550205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS ONE. 2021;16:e0260568. doi: 10.1371/journal.pone.0260568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021;39:1282&#x2013;92. doi: 10.1097/HJH.0000000000002819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002819</ArticleId><ArticleId IdType="pmc">PMC9904438</ArticleId><ArticleId IdType="pubmed">33687179</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;64. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&amp;isAllowed=y. Accessed 25 Dec 2022.</Citation></Reference><Reference><Citation>National Institute for Health. National Institute for Health and Care Excellence: Clinical Guidelines. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020. Copyright &#xa9; NICE 2020.</Citation></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;72. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;58. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9:1275&#x2013;87. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Lambadiari V, Mitrakou A, Kountouri A, Katogiannis K, Thymis J, et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur J Heart Fail. 2022;24:727&#x2013;9. doi: 10.1002/ejhf.2451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2451</ArticleId><ArticleId IdType="pmc">PMC9087421</ArticleId><ArticleId IdType="pubmed">35138689</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J. 2022;43:1124&#x2013;37. doi: 10.1093/eurheartj/ehab914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vasc Pharmacol. 2022;144:106975. doi: 10.1016/j.vph.2022.106975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA. Cardiol. 2020;5:1265&#x2013;73. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Baumhardt M, Hartveg P, Hoyo L, H&#xfc;ll E, Imhof A, et al. Long COVID: distinction between organ damage and deconditioning. J Clin Med. 2021;10:3782. doi: 10.3390/jcm10173782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173782</ArticleId><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li R, Zhou Z, Jiang H, Yan Z, Tao X, et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23:14. doi: 10.1186/s12968-021-00710-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00710-x</ArticleId><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Crea F. European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID. Eur Heart J. 2022;43:1017&#x2013;21. doi: 10.1093/eurheartj/ehac087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac087</ArticleId><ArticleId IdType="pubmed">35284919</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain. 2021;144:3576&#x2013;88. doi: 10.1093/brain/awab302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Khoury JA, Blair JE, Grill MF. COVID-19 Dysautonomia. Front Neurol. 2021;12:624968. doi: 10.3389/fneur.2021.624968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;94. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci. 2022;21:77. doi: 10.31083/j.jin2103077.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang SW, Leonard BE, Helmeste DM. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr. 2022;34:109&#x2013;26. doi: 10.1017/neu.2022.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.6</ArticleId><ArticleId IdType="pubmed">35144718</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J, Reimer KC, Nagai JS, Varghese FS, Overheul GJ, de Beer M, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29:217&#x2013;31. doi: 10.1016/j.stem.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32:2851&#x2013;62. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X, Huang L, Cui D, Wang Y, Wang Y, Xu J, et al. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: a cohort study. EBioMedicine. 2022;76:103817. doi: 10.1016/j.ebiom.2022.103817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103817</ArticleId><ArticleId IdType="pmc">PMC8776508</ArticleId><ArticleId IdType="pubmed">35074630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstrom M, Lipcsey M, Wallin E, Larsson IM, Larsson A, Frithiof R. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care. 2021;25:37. doi: 10.1186/s13054-021-03461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03461-4</ArticleId><ArticleId IdType="pmc">PMC7829656</ArticleId><ArticleId IdType="pubmed">33494766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021;4:e211095. doi: 10.1001/jamanetworkopen.2021.1095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.1095</ArticleId><ArticleId IdType="pmc">PMC7948062</ArticleId><ArticleId IdType="pubmed">33688965</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockmann H, Hardenberg JB, Aigner A, Hinze C, Gotthardt I, Stier B, et al. High rates of long-term renal recovery in survivors of coronavirus disease 2019-associated acute kidney injury requiring kidney replacement therapy. Kidney Int. 2021;99:1021&#x2013;2. doi: 10.1016/j.kint.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7839389</ArticleId><ArticleId IdType="pubmed">33515574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2&#x2019;s reliance on ACE2. Endocrinology. 2020;161:bqaa108. doi: 10.1210/endocr/bqaa108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa108</ArticleId><ArticleId IdType="pmc">PMC7454499</ArticleId><ArticleId IdType="pubmed">32652001</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, et al. The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis. Endocr Pract. 2021;27:83&#x2013;9. doi: 10.1016/j.eprac.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E, Karaca Z, Unuvar GK, Gundogan K, Unluhizarci K. Investigation of pituitary functions after acute coronavirus disease 2019. Endocr J. 2022;69:649&#x2013;58. doi: 10.1507/endocrj.EJ21-0531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ21-0531</ArticleId><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Phylactou M, Patel B, Mills EG, Muzi B, Izzi-Engbeaya C, et al. Normal adrenal and thyroid function in patients who survive COVID-19 infection. J Clin Endocrinol Metab. 2021;106:2208&#x2013;20. doi: 10.1210/clinem/dgab349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab349</ArticleId><ArticleId IdType="pmc">PMC8194556</ArticleId><ArticleId IdType="pubmed">34008009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Campenni A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones. 2021;20:219&#x2013;21. doi: 10.1007/s42000-020-00230-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-020-00230-w</ArticleId><ArticleId IdType="pmc">PMC7365600</ArticleId><ArticleId IdType="pubmed">32676935</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarnywojtek A, Ochmanska A, Zgorzalewicz-Stachowiak M, Sawicka-Gutaj N, Matyjaszek-Matuszek B, Wozniak M, et al. Influence of SARS-CoV-2 infection on thyroid gland function: the current knowledge. Adv Clin Exp Med. 2021;30:747&#x2013;55. doi: 10.17219/acem/139622.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/139622</ArticleId><ArticleId IdType="pubmed">34286519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: a cause of recurrent Graves&#x2019; hyperthyroidism? J Endocrinol Invest. 2021;44:387&#x2013;8. doi: 10.1007/s40618-020-01440-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01440-0</ArticleId><ArticleId IdType="pmc">PMC7538276</ArticleId><ArticleId IdType="pubmed">33025554</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res. 2022;50:3000605221082898. doi: 10.1177/03000605221082898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605221082898</ArticleId><ArticleId IdType="pmc">PMC8894980</ArticleId><ArticleId IdType="pubmed">35226548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto T, Kang S. IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19. Annu Rev Immunol. 2022;40:323&#x2013;48. doi: 10.1146/annurev-immunol-101220-023458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101220-023458</ArticleId><ArticleId IdType="pubmed">35113729</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, et al. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves&#x2019; disease. J Clin Endocrinol Metab. 1996;81:2976&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8768861</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al. Thyroid ter COVID-19. J Clin Endocrinol Metab. 2021;106:e803&#x2013;11. doi: 10.1210/clinem/dgaa830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa830</ArticleId><ArticleId IdType="pmc">PMC7823247</ArticleId><ArticleId IdType="pubmed">33180932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y, Yamamoto K, Tokumasu K, Sakurada Y, et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr J. 2022;69:1173&#x2013;81. doi: 10.1507/endocrj.EJ22-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Guruparan T, Siddiqi S, Sheth R, Jacyna M, Naghibi M, et al. A case of adrenal infarction in a patient with COVID 19 infection. BJR Case Rep. 2020;6:20200075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465735</ArticleId><ArticleId IdType="pubmed">32922854</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkhouly MMN, Elazzab AA, Moghul SS. Bilateral adrenal hemorrhage in a man with severe COVID-19 pneumonia. Radio Case Rep. 2021;16:1438&#x2013;42. doi: 10.1016/j.radcr.2021.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2021.03.032</ArticleId><ArticleId IdType="pmc">PMC7998055</ArticleId><ArticleId IdType="pubmed">33815638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakhshoori M, Heidarpour M, Bondariyan N, Sadeghpour N, Mousavi Z. Adrenal insufficiency in coronavirus disease 2019 (COVID-19)-infected patients without preexisting adrenal diseases: a systematic literature review. Int J Endocrinol. 2021;2021:2271514. doi: 10.1155/2021/2271514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/2271514</ArticleId><ArticleId IdType="pmc">PMC8443384</ArticleId><ArticleId IdType="pubmed">34539780</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzano C, Saracino G, Cardillo G. Possible adrenal involvement in long COVID syndrome. Medicina. 2021;57:1087. doi: 10.3390/medicina57101087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101087</ArticleId><ArticleId IdType="pmc">PMC8537520</ArticleId><ArticleId IdType="pubmed">34684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Beuschlein F, Bornstein SR. Is there a role for the adrenal glands in long COVID? Nat Rev Endocrinol. 2022;18:451&#x2013;2. doi: 10.1038/s41574-022-00700-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00700-8</ArticleId><ArticleId IdType="pmc">PMC9150041</ArticleId><ArticleId IdType="pubmed">35637413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Guan C, Chen R, Wang Y, Feng S, Wang R, et al. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients. Cell Mol Immunol. 2021;18:487&#x2013;9. doi: 10.1038/s41423-020-00604-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00604-5</ArticleId><ArticleId IdType="pmc">PMC7734388</ArticleId><ArticleId IdType="pubmed">33318629</ArticleId></ArticleIdList></Reference><Reference><Citation>La Marca A, Busani S, Donno V, Guaraldi G, Ligabue G, Girardis M. Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis. Reprod Biomed Online. 2020;41:903&#x2013;6. doi: 10.1016/j.rbmo.2020.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.07.017</ArticleId><ArticleId IdType="pmc">PMC7377719</ArticleId><ArticleId IdType="pubmed">32826162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridwell RE, Merrill DR, Griffith SA, Wray J, Oliver JJ. A coronavirus disease 2019 (COVID-19) patient with bilateral orchitis. Am J Emerg Med. 2021;42:260.e3&#x2013;5. doi: 10.1016/j.ajem.2020.08.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.08.068</ArticleId><ArticleId IdType="pmc">PMC7449893</ArticleId><ArticleId IdType="pubmed">32888763</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai S, Citrin D, Conneely M. Testicular pain and mesenteric adenitis as an atypical presentation of COVID-19. Cureus. 2021;13:e15956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236304</ArticleId><ArticleId IdType="pubmed">34211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ediz C, Tavukcu HH, Akan S, Kizilkan YE, Alcin A, Oz K, et al. Is there any association of COVID-19 with testicular pain and epididymo-orchitis? Int J Clin Pract. 2021;75:e13753. doi: 10.1111/ijcp.13753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13753</ArticleId><ArticleId IdType="pmc">PMC7646040</ArticleId><ArticleId IdType="pubmed">33063899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Thomsen T, Sell N, Goldsmith AJ. Abdominal and testicular pain: an atypical presentation of COVID-19. Am J Emerg Med. 2020;38:1542.e1&#x2013;3. doi: 10.1016/j.ajem.2020.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.03.052</ArticleId><ArticleId IdType="pmc">PMC7138186</ArticleId><ArticleId IdType="pubmed">32273141</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020;114:233&#x2013;8. doi: 10.1016/j.fertnstert.2020.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2020.05.028</ArticleId><ArticleId IdType="pmc">PMC7256599</ArticleId><ArticleId IdType="pubmed">32650948</ArticleId></ArticleIdList></Reference><Reference><Citation>Temiz MZ, Dincer MM, Hacibey I, Yazar RO, Celik C, Kucuk SH, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia. 2021;53:e13912. doi: 10.1111/and.13912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/and.13912</ArticleId><ArticleId IdType="pmc">PMC7744846</ArticleId><ArticleId IdType="pubmed">33244788</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini-review. Endocrinology. 2022;163:bqab203. doi: 10.1210/endocr/bqab203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqab203</ArticleId><ArticleId IdType="pmc">PMC8500009</ArticleId><ArticleId IdType="pubmed">34543404</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 1985;60:444&#x2013;50. doi: 10.1210/jcem-60-3-444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-60-3-444</ArticleId><ArticleId IdType="pubmed">3919042</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ, Wu Z, Ghoshal AK, Erlich EC, et al. Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA Netw Open. 2021;4:e2111398. doi: 10.1001/jamanetworkopen.2021.11398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11398</ArticleId><ArticleId IdType="pmc">PMC8150664</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh Maleki B, Tartibian B. COVID-19 and male reproductive function: a prospective, longitudinal cohort study. Reproduction. 2021;161:319&#x2013;31. doi: 10.1530/REP-20-0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-20-0382</ArticleId><ArticleId IdType="pubmed">33522983</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan N, Behan LA, Owens L. The impact of the COVID-19 pandemic on women&#x2019;s reproductive health. Front Endocrinol. 2021;12:642755. doi: 10.3389/fendo.2021.642755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.642755</ArticleId><ArticleId IdType="pmc">PMC8030584</ArticleId><ArticleId IdType="pubmed">33841334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T, Wang T, Zhang J, Cui P, Chen Z, Zhou S, et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front Med. 2021;8:635255. doi: 10.3389/fmed.2021.635255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.635255</ArticleId><ArticleId IdType="pmc">PMC8017139</ArticleId><ArticleId IdType="pubmed">33816526</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Chen G, Hou H, Liao Q, Chen J, Bai H, et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online. 2021;42:260&#x2013;7. doi: 10.1016/j.rbmo.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7522626</ArticleId><ArticleId IdType="pubmed">33288478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, Duarte-Neto AN, Soares Gomes-Gouvea M, Viu, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc Health. 2020;4:790&#x2013;4. doi: 10.1016/S2352-4642(20)30257-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30257-1</ArticleId><ArticleId IdType="pmc">PMC7440866</ArticleId><ArticleId IdType="pubmed">32828177</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;8. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol. 2022;164:69&#x2013;82. doi: 10.1016/j.yjmcc.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;7. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;60. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Anton-Plagaro C, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861&#x2013;5. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, Wan L, Yan Q, Wang X, Zhang J, Yang X, et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020;2:1391&#x2013;400. doi: 10.1038/s42255-020-00324-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00324-0</ArticleId><ArticleId IdType="pubmed">33244168</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature. 2019;569:565&#x2013;9. doi: 10.1038/s41586-019-1140-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1140-4</ArticleId><ArticleId IdType="pmc">PMC6631346</ArticleId><ArticleId IdType="pubmed">31019307</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Xia C, Olejnik J, White MR, Napoleon MA, Lotfollahzadeh S, et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc Natl Acad Sci USA. 2022;119:e2113874119. doi: 10.1073/pnas.2113874119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283. doi: 10.1038/s41392-020-00426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugatti A, Filippini F, Bardelli M, Zani A, Chiodelli P, Messali S, et al. SARS-CoV-2 infects human ACE2-negative endothelial cells through an alphavbeta3 integrin-mediated endocytosis even in the presence of vaccine-elicited neutralizing antibodies. Viruses. 2022;14:705. doi: 10.3390/v14040705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040705</ArticleId><ArticleId IdType="pmc">PMC9032829</ArticleId><ArticleId IdType="pubmed">35458435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Larabee JL, Gao L, Shi H, Shao B, Hoover CM, et al. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI Insight. 2021;6:e148999. doi: 10.1172/jci.insight.148999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148999</ArticleId><ArticleId IdType="pmc">PMC8410055</ArticleId><ArticleId IdType="pubmed">34291736</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S, Leo MD. Histamine potentiates SARS-CoV-2 spike protein entry into endothelial cells. Front Pharmacol. 2022;13:872736. doi: 10.3389/fphar.2022.872736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.872736</ArticleId><ArticleId IdType="pmc">PMC9084361</ArticleId><ArticleId IdType="pubmed">35548336</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, et al. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin. J Virol. 2021;95:e0139621. doi: 10.1128/JVI.01396-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01396-21</ArticleId><ArticleId IdType="pmc">PMC8577385</ArticleId><ArticleId IdType="pubmed">34549987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323&#x2013;6. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Terentes-Printzios D, Gardikioti V, Solomou E, Emmanouil E, Gourgouli I, Xydis P, et al. The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness. Hypertens Res. 2022;45:846&#x2013;55. doi: 10.1038/s41440-022-00876-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-00876-6</ArticleId><ArticleId IdType="pmc">PMC8907903</ArticleId><ArticleId IdType="pubmed">35273351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogi M. Is COVID-19 vaccination beneficial or harmful to endothelial cells? Hypertens Res. 2022;45:920&#x2013;1. doi: 10.1038/s41440-022-00878-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-00878-4</ArticleId><ArticleId IdType="pmc">PMC8883243</ArticleId><ArticleId IdType="pubmed">35228713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner JUG, Bojkova D, Shumliakivska M, Luxan G, Nicin L, Aslan GS, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol. 2021;116:42. doi: 10.1007/s00395-021-00882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00882-8</ArticleId><ArticleId IdType="pmc">PMC8256413</ArticleId><ArticleId IdType="pubmed">34224022</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, et al. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunol. 2021;10:e1350. doi: 10.1002/cti2.1350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1350</ArticleId><ArticleId IdType="pmc">PMC8542944</ArticleId><ArticleId IdType="pubmed">34721846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol. 2016;13:432&#x2013;42. doi: 10.1038/cmi.2016.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2016.1</ArticleId><ArticleId IdType="pmc">PMC4947825</ArticleId><ArticleId IdType="pubmed">27041635</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227:75&#x2013;86. doi: 10.1111/j.1600-065X.2008.00737.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13:3&#x2013;10. doi: 10.1038/cmi.2015.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2015.74</ArticleId><ArticleId IdType="pmc">PMC4711683</ArticleId><ArticleId IdType="pubmed">26189369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21:319&#x2013;29. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2013;79. doi: 10.1182/blood.2020007008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007008</ArticleId><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrover JM, Carrau L, Dassler-Plenker J, Bram Y, Chandar V, Houghton S, et al. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection. JCI Insight. 2022;7:e157342. doi: 10.1172/jci.insight.157342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.157342</ArticleId><ArticleId IdType="pmc">PMC8983145</ArticleId><ArticleId IdType="pubmed">35133984</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217:e20200652. doi: 10.1084/jem.20200652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200652</ArticleId><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin JM, Quer G, Ramos E, Baca-Motes K, Gadaleta M, Topol EJ, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open. 2021;4:e2115959. doi: 10.1001/jamanetworkopen.2021.15959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.15959</ArticleId><ArticleId IdType="pmc">PMC8264646</ArticleId><ArticleId IdType="pubmed">34232306</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques KC, Silva CC, Trindade SDS, Santos MCS, Rocha RSB, Vasconcelos P, et al. Reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long COVID. Front Cardiovasc Med. 2022;9:862001. doi: 10.3389/fcvm.2022.862001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.862001</ArticleId><ArticleId IdType="pmc">PMC9098798</ArticleId><ArticleId IdType="pubmed">35571200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills RJ, Humphrey SJ, Fortuna PRJ, Lor M, Foster SR, Quaife-Ryan GA, et al. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection. Cell. 2021;184:2167&#x2013;82. doi: 10.1016/j.cell.2021.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.026</ArticleId><ArticleId IdType="pmc">PMC7962543</ArticleId><ArticleId IdType="pubmed">33811809</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CH, Vallejo JG, Kollias G, Mann DL. Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol. 2009;104:228&#x2013;37. doi: 10.1007/s00395-008-0765-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-008-0765-5</ArticleId><ArticleId IdType="pmc">PMC4541794</ArticleId><ArticleId IdType="pubmed">19159057</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2001;38:1773&#x2013;81. doi: 10.1016/S0735-1097(01)01654-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01654-0</ArticleId><ArticleId IdType="pubmed">11738273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19:63&#x2013;4. doi: 10.1038/s41577-018-0098-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0098-z</ArticleId><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295&#x2013;301. doi: 10.1038/s41586-021-04142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286&#x2013;92. doi: 10.1056/NEJM199411103311907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199411103311907</ArticleId><ArticleId IdType="pubmed">7935686</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, et al. The pathogenesis and long-term consequences of COVID-19 cardiac injury. JACC Basic Transl Sci. 2022;7:294&#x2013;308. doi: 10.1016/j.jacbts.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8828362</ArticleId><ArticleId IdType="pubmed">35165665</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C, et al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. 2022;225:2155&#x2013;62. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O, Varionchik N, Zaidenov V, Savina P, Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol. 2021;51:893&#x2013;902. doi: 10.1002/eji.202048930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048930</ArticleId><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, Forrest JC, Boehme KW, Kennedy JL, Owens S, Herzog C, et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51:296&#x2013;9. doi: 10.1016/j.idnow.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7816954</ArticleId><ArticleId IdType="pubmed">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11:10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Muneuchi J, Ohga S, Ishimura M, Ikeda K, Yamaguchi K, Nomura A, et al. Cardiovascular complications associated with chronic active Epstein-Barr virus infection. Pediatr Cardiol. 2009;30:274&#x2013;81. doi: 10.1007/s00246-008-9343-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-008-9343-8</ArticleId><ArticleId IdType="pubmed">19184184</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Hu B, Luo R, Hu H, Zhang J, Kuang W, et al. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis. Virol J. 2020;17:166. doi: 10.1186/s12985-020-01409-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01409-8</ArticleId><ArticleId IdType="pmc">PMC7597064</ArticleId><ArticleId IdType="pubmed">33121509</ArticleId></ArticleIdList></Reference><Reference><Citation>Binkley PF, Cooke GE, Lesinski A, Taylor M, Chen M, Laskowski B, et al. Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events. PLoS ONE. 2013;8:e54008. doi: 10.1371/journal.pone.0054008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054008</ArticleId><ArticleId IdType="pmc">PMC3547968</ArticleId><ArticleId IdType="pubmed">23349778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Peng G, Bai J, He B, Huang K, Hu X, et al. Cytomegalovirus infection and relative risk of cardiovascular disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): a meta-analysis of prospective studies up to 2016. J Am Heart Assoc. 2017;6:e005025. doi: 10.1161/JAHA.116.005025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.005025</ArticleId><ArticleId IdType="pmc">PMC5586265</ArticleId><ArticleId IdType="pubmed">28684641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112:1965&#x2013;70. doi: 10.1161/CIRCULATIONAHA.105.548156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548156</ArticleId><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, et al. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat Aging. 2022;2:115&#x2013;24. doi: 10.1038/s43587-022-00170-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00170-7</ArticleId><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599:283&#x2013;9. doi: 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell CD, Yousefzadeh MJ, Zhu Y, Prata L, Huggins MA, Pierson M, et al. Senolytics reduce coronavirus-related mortality in old mice. Science. 2021;373:eabe4832. doi: 10.1126/science.abe4832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe4832</ArticleId><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505&#x2013;22. doi: 10.1038/s41569-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5:434&#x2013;5. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Investig. 2021;131:e149633. doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020;319:H1227&#x2013;33. doi: 10.1152/ajpheart.00612.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00612.2020</ArticleId><ArticleId IdType="pmc">PMC7792706</ArticleId><ArticleId IdType="pubmed">32986965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;55. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;52. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124:1045&#x2013;60. doi: 10.1161/CIRCRESAHA.118.313236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313236</ArticleId><ArticleId IdType="pubmed">30920928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto K, Yamamoto K. Hypertension, the decline of activities of daily living (ADL) and frailty. Hypertens Res. 2022;45:629&#x2013;34. doi: 10.1038/s41440-021-00846-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-021-00846-4</ArticleId><ArticleId IdType="pubmed">35082375</ArticleId></ArticleIdList></Reference><Reference><Citation>Covino M, Russo A, Salini S, De Matteis G, Simeoni B, Della Polla D, et al. Frailty assessment in the emergency department for risk stratification of COVID-19 patients aged &gt;/=80 years. J Am Med Dir Assoc. 2021;22:1845&#x2013;52. doi: 10.1016/j.jamda.2021.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.005</ArticleId><ArticleId IdType="pmc">PMC8289672</ArticleId><ArticleId IdType="pubmed">34364846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini S, Di Rosa M, Soraci L, Fumagalli A, Misuraca C, Colombo D, et al. Chest X-ray score and frailty as predictors of in-hospital mortality in older adults with COVID-19. J Clin Med. 2021;10:2965. doi: 10.3390/jcm10132965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132965</ArticleId><ArticleId IdType="pmc">PMC8268684</ArticleId><ArticleId IdType="pubmed">34279449</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon NR, Jauslin AS, Rueegg M, Twerenbold R, Lampart M, Osswald S, et al. Association of frailty with adverse outcomes in patients with suspected COVID-19 infection. J Clin Med. 2021;10:2472. doi: 10.3390/jcm10112472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112472</ArticleId><ArticleId IdType="pmc">PMC8199640</ArticleId><ArticleId IdType="pubmed">34199572</ArticleId></ArticleIdList></Reference><Reference><Citation>Koduri G, Gokaraju S, Darda M, Warrier V, Duta I, Hayes F, et al. Clinical frailty score as an independent predictor of outcome in COVID-19 hospitalised patients. Eur Geriatr Med. 2021;12:1065&#x2013;73. doi: 10.1007/s41999-021-00508-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-021-00508-1</ArticleId><ArticleId IdType="pmc">PMC8175234</ArticleId><ArticleId IdType="pubmed">34086193</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Esteban EM, Quintana-Diaz M, Ramirez-Cervantes KL, Benayas-Pena I, Silva-Obregon A, Magallon-Botaya R, et al. Outcomes of hospitalized patients with COVID-19 according to level of frailty. PeerJ. 2021;9:e11260. doi: 10.7717/peerj.11260.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.11260</ArticleId><ArticleId IdType="pmc">PMC8051355</ArticleId><ArticleId IdType="pubmed">33954054</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomaard LC, van der Linden CMJ, van der Bol JM, Jansen SWM, Polinder-Bos HA, Willems HC, et al. Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study. Age Ageing. 2021;50:631&#x2013;40. doi: 10.1093/ageing/afab018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab018</ArticleId><ArticleId IdType="pmc">PMC7929372</ArticleId><ArticleId IdType="pubmed">33951156</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliberti MJR, Szlejf C, Avelino-Silva VI, Suemoto CK, Apolinario D, Dias MB, et al. COVID-19 is not over and age is not enough: Using frailty for prognostication in hospitalized patients. J Am Geriatr Soc. 2021;69:1116&#x2013;27. doi: 10.1111/jgs.17146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17146</ArticleId><ArticleId IdType="pmc">PMC8251205</ArticleId><ArticleId IdType="pubmed">33818759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sablerolles RSG, Lafeber M, van Kempen JAL, van de Loo BPA, Boersma E, Rietdijk WJR, et al. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study. Lancet Healthy Longev. 2021;2:e163&#x2013;70. doi: 10.1016/S2666-7568(21)00006-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(21)00006-4</ArticleId><ArticleId IdType="pmc">PMC7906710</ArticleId><ArticleId IdType="pubmed">33655235</ArticleId></ArticleIdList></Reference><Reference><Citation>Geriatric Medicine Research Collaborative. Covid Collaborative, Welch C. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age Ageing. 2021;50:617&#x2013;30. doi: 10.1093/ageing/afab026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab026</ArticleId><ArticleId IdType="pmc">PMC7929433</ArticleId><ArticleId IdType="pubmed">33543243</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilis M, Chagrot N, Koeberle S, Tannou T, Brunel AS, Chirouze C, et al. Older adults with SARS-CoV-2 infection: Utility of the clinical frailty scale to predict mortality. J Med Virol. 2021;93:2453&#x2013;60. doi: 10.1002/jmv.26766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26766</ArticleId><ArticleId IdType="pubmed">33377529</ArticleId></ArticleIdList></Reference><Reference><Citation>Marengoni A, Zucchelli A, Vetrano DL, Armellini A, Botteri E, Nicosia F, et al. Beyond chronological age: frailty and multimorbidity predict in-hospital mortality in patients with coronavirus disease 2019. J Gerontol A Biol Sci Med Sci. 2021;76:e38&#x2013;45. doi: 10.1093/gerona/glaa291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa291</ArticleId><ArticleId IdType="pmc">PMC7717138</ArticleId><ArticleId IdType="pubmed">33216846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani S, Killander A, Astrand P, Jakobsson J, Gille-Johnson P. Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients. Int J Infect Dis. 2021;102:415&#x2013;21. doi: 10.1016/j.ijid.2020.10.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.071</ArticleId><ArticleId IdType="pmc">PMC7833745</ArticleId><ArticleId IdType="pubmed">33130213</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnadurai R, Ogedengbe O, Agarwal P, Money-Coomes S, Abdurrahman AZ, Mohammed S, et al. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr. 2020;20:409. doi: 10.1186/s12877-020-01803-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01803-5</ArticleId><ArticleId IdType="pmc">PMC7563906</ArticleId><ArticleId IdType="pubmed">33066750</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen RK, Conroy SP, Taub N, Jones W, Bryden D, Pareek M, et al. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing. 2021;50:307&#x2013;16. doi: 10.1093/ageing/afaa167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa167</ArticleId><ArticleId IdType="pmc">PMC7454252</ArticleId><ArticleId IdType="pubmed">32678866</ArticleId></ArticleIdList></Reference><Reference><Citation>De Smet R, Mellaerts B, Vandewinckele H, Lybeert P, Frans E, Ombelet S, et al. Frailty and mortality in hospitalized older adults With COVID-19: retrospective observational study. J Am Med Dir Assoc. 2020;21:928&#x2013;32. doi: 10.1016/j.jamda.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7280137</ArticleId><ArticleId IdType="pubmed">32674821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5:e444&#x2013;51. doi: 10.1016/S2468-2667(20)30146-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30146-8</ArticleId><ArticleId IdType="pmc">PMC7326416</ArticleId><ArticleId IdType="pubmed">32619408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebora P, Foca E, Salvatori A, Zucchelli A, Ceravolo I, Ornago AM, et al. The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study. Panminerva Med. 2022;64:24&#x2013;30. doi: 10.23736/S0031-0808.21.04506-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0031-0808.21.04506-7</ArticleId><ArticleId IdType="pubmed">34761887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JP, Low KYH, Lin NJJ, Lim CZQ, Ong SWX, Tan WYT, et al. Predictors for development of critical illness amongst older adults with COVID-19: Beyond age to age-associated factors. Arch Gerontol Geriatr. 2021;94:104331. doi: 10.1016/j.archger.2020.104331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2020.104331</ArticleId><ArticleId IdType="pmc">PMC7834606</ArticleId><ArticleId IdType="pubmed">33476755</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig K, Lambe M, Ahlbom A, Ebeling M. Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: a population-based study. Lancet Reg Health Eur. 2021;4:100072. doi: 10.1016/j.lanepe.2021.100072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100072</ArticleId><ArticleId IdType="pmc">PMC8454796</ArticleId><ArticleId IdType="pubmed">34557812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, Ungar A, Rozzini R, Vannini M, Coccia F, Cesaroni G, et al. Predicting mortality risk in older hospitalized persons with COVID-19: a comparison of the COVID-19 mortality risk score with frailty and disability. J Am Med Dir Assoc. 2021;22:1588&#x2013;92. doi: 10.1016/j.jamda.2021.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.05.028</ArticleId><ArticleId IdType="pmc">PMC8249822</ArticleId><ArticleId IdType="pubmed">34334160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundi H, Cetin EHO, Canpolat U, Aras S, Celik O, Ata N, et al. The role of frailty on adverse outcomes among older patients with COVID-19. J Infect. 2020;81:944&#x2013;51. doi: 10.1016/j.jinf.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.09.029</ArticleId><ArticleId IdType="pmc">PMC7521439</ArticleId><ArticleId IdType="pubmed">33002560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Hou L, Yang X, Huang Z, Yang X, Zhao N, et al. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC Med. 2020;18:274. doi: 10.1186/s12916-020-01761-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01761-0</ArticleId><ArticleId IdType="pmc">PMC7474968</ArticleId><ArticleId IdType="pubmed">32892742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagg S, Jylhava J, Wang Y, Xu H, Metzner C, Annetorp M, et al. Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care. J Am Med Dir Assoc. 2020;21:1555&#x2013;9. doi: 10.1016/j.jamda.2020.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.08.014</ArticleId><ArticleId IdType="pmc">PMC7427570</ArticleId><ArticleId IdType="pubmed">32978065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Han M, Wang J, Zhao J, Gan H, Yang Y. Predictive value of frailty in the mortality of hospitalized patients with COVID-19: a systematic review and meta-analysis. Ann Transl Med. 2022;10:166. doi: 10.21037/atm-22-274.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-22-274</ArticleId><ArticleId IdType="pmc">PMC8908186</ArticleId><ArticleId IdType="pubmed">35280387</ArticleId></ArticleIdList></Reference><Reference><Citation>Rottler M, Ocskay K, Sipos Z, Gorbe A, Virag M, Hegyi P, et al. Clinical Frailty Scale (CFS) indicated frailty is associated with increased in-hospital and 30-day mortality in COVID-19 patients: a systematic review and meta-analysis. Ann Intensive Care. 2022;12:17. doi: 10.1186/s13613-021-00977-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00977-4</ArticleId><ArticleId IdType="pmc">PMC8858439</ArticleId><ArticleId IdType="pubmed">35184215</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitrascu F, Branje KE, Hladkowicz ES, Lalu M, McIsaac DI. Association of frailty with outcomes in individuals with COVID-19: a living review and meta-analysis. J Am Geriatr Soc. 2021;69:2419&#x2013;29. doi: 10.1111/jgs.17299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17299</ArticleId><ArticleId IdType="pmc">PMC8242611</ArticleId><ArticleId IdType="pubmed">34048599</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosco TD, Best J, Davis D, Bryden D, Arkill S, van Oppen J, et al. What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review. Age Ageing. 2021;50:608&#x2013;16. doi: 10.1093/ageing/afab008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab008</ArticleId><ArticleId IdType="pmc">PMC7929406</ArticleId><ArticleId IdType="pubmed">33951151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hasan SS, Thiruchelvam K, Aldeyab M. Association of frailty and mortality in patients with COVID-19: a meta-analysis. Br J Anaesth. 2021;126:e108&#x2013;10. doi: 10.1016/j.bja.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7836844</ArticleId><ArticleId IdType="pubmed">33358046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R, Henrina J, Lim MA, Lawrensia S, Yonas E, Vania R, et al. Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis. Arch Gerontol Geriatr. 2021;93:104324. doi: 10.1016/j.archger.2020.104324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2020.104324</ArticleId><ArticleId IdType="pmc">PMC7832565</ArticleId><ArticleId IdType="pubmed">33352430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastora S, Kounidas G, Perrott S, Carter B, Hewitt J, Myint PK. Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100896. doi: 10.1016/j.eclinm.2021.100896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100896</ArticleId><ArticleId IdType="pmc">PMC8141355</ArticleId><ArticleId IdType="pubmed">34036252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud M, Carmisciano L, Tagliafico L, Muzyka M, Rosa G, Signori A, et al. Patterns of comorbidity and in-hospital mortality in older patients with COVID-19 infection. Front Med. 2021;8:726837. doi: 10.3389/fmed.2021.726837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.726837</ArticleId><ArticleId IdType="pmc">PMC8486012</ArticleId><ArticleId IdType="pubmed">34604262</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachogiannis NI, Baker KF, Georgiopoulos G, Lazaridis C, van der Loeff IS, Hanrath AT, et al. Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13:1502&#x2013;13. doi: 10.1002/jcsm.12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12966</ArticleId><ArticleId IdType="pmc">PMC9088314</ArticleId><ArticleId IdType="pubmed">35257497</ArticleId></ArticleIdList></Reference><Reference><Citation>Braude P, McCarthy K, Strawbridge R, Short R, Verduri A, Vilches-Moraga A, et al. Frailty is associated with poor mental health 1 year after hospitalisation with COVID-19. J Affect Disord. 2022;310:377&#x2013;83. doi: 10.1016/j.jad.2022.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.05.035</ArticleId><ArticleId IdType="pmc">PMC9091159</ArticleId><ArticleId IdType="pubmed">35568322</ArticleId></ArticleIdList></Reference><Reference><Citation>Combret Y, Kerne G, Pholoppe F, Tonneville B, Plate L, Marques MH, et al. Remote assessment of quality of life and functional exercise capacity in a cohort of COVID-19 patients one year after hospitalization (TELECOVID) J Clin Med. 2022;11:905. doi: 10.3390/jcm11040905.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11040905</ArticleId><ArticleId IdType="pmc">PMC8877482</ArticleId><ArticleId IdType="pubmed">35207176</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman IW, Leaver S, Flaatten H, Fjolner J, Wernly B, Bruno RR, et al. Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70 years. Age Ageing. 2022;51:afab278. doi: 10.1093/ageing/afab278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab278</ArticleId><ArticleId IdType="pmc">PMC8825757</ArticleId><ArticleId IdType="pubmed">35136896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, et al. Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. 2022;97:36&#x2013;41. doi: 10.1016/j.ejim.2021.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I, Mancinetti M, Renner A, Bridevaux PO, Brutsche MH, Clarenbach C, et al. Frailty assessment for COVID-19 follow-up: a prospective cohort study. BMJ Open Respir Res. 2022;9:e001227. doi: 10.1136/bmjresp-2022-001227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2022-001227</ArticleId><ArticleId IdType="pmc">PMC9035838</ArticleId><ArticleId IdType="pubmed">35459694</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327:559&#x2013;65. doi: 10.1001/jama.2022.0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.0040</ArticleId><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi LU, Avelino-Silva TJ, Dias MB, Jacob-Filho W, Aliberti MJR, Covid. et al. Patient-centered outcomes following COVID-19: frailty and disability transitions in critical care survivors. Crit Care Med. 2022;50:955&#x2013;63. doi: 10.1097/CCM.0000000000005488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005488</ArticleId><ArticleId IdType="pmc">PMC9112506</ArticleId><ArticleId IdType="pubmed">35081061</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco GI, Noale M, Trevisan C, Zatti G, Dalla Pozza M, Lazzarin M, et al. Increase in frailty in nursing home survivors of coronavirus disease 2019: comparison with noninfected residents. J Am Med Dir Assoc. 2021;22:943&#x2013;7. doi: 10.1016/j.jamda.2021.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7898983</ArticleId><ArticleId IdType="pubmed">33757725</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira MR, Sudati IP, Konzen VM, de Campos AC, Wibelinger LM, Correa C, et al. Covid-19 and the impact on the physical activity level of elderly people: a systematic review. Exp Gerontol. 2022;159:111675. doi: 10.1016/j.exger.2021.111675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2021.111675</ArticleId><ArticleId IdType="pmc">PMC8695515</ArticleId><ArticleId IdType="pubmed">34954282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Kimura Y, Ishiyama D, Otobe Y, Suzuki M, Koyama S, et al. The influence of the COVID-19 pandemic on physical activity and new incidence of frailty among initially non-frail older adults in japan: a follow-up online survey. J Nutr Health Aging. 2021;25:751&#x2013;6. doi: 10.1007/s12603-021-1634-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-021-1634-2</ArticleId><ArticleId IdType="pmc">PMC8074704</ArticleId><ArticleId IdType="pubmed">34179929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura K, Kamiya M, Suzumura S, Maki K, Ueda I, Itoh N, et al. Impact of the coronavirus disease 2019 outbreak on activity and exercise levels among older patients. J Nutr Health Aging. 2021;25:921&#x2013;5. doi: 10.1007/s12603-021-1648-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-021-1648-9</ArticleId><ArticleId IdType="pmc">PMC8231075</ArticleId><ArticleId IdType="pubmed">34409972</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara T, Saida K, Tanaka S, Murayama A, Higuchi D. Transition to frailty in older Japanese people during the coronavirus disease 2019 pandemic: a prospective cohort study. Arch Gerontol Geriatr. 2022;98:104562. doi: 10.1016/j.archger.2021.104562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2021.104562</ArticleId><ArticleId IdType="pmc">PMC8524810</ArticleId><ArticleId IdType="pubmed">34715458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Fu P, Li J, Jing Z, Wang Q, Zhao D, et al. Changes in psychological distress before and during the COVID-19 pandemic among older adults: the contribution of frailty transitions and multimorbidity. Age Ageing. 2021;50:1011&#x2013;8. doi: 10.1093/ageing/afab061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab061</ArticleId><ArticleId IdType="pmc">PMC7989653</ArticleId><ArticleId IdType="pubmed">33710264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocyigit SE, Soysal P, Bulut EA, Aydin AE, Dokuzlar O, Isik AT. What is the relationship between frailty and orthostatic hypotension in older adults? J Geriatr Cardiol. 2019;16:272&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500562</ArticleId><ArticleId IdType="pubmed">31080470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol A, Slangen LRN, Trappenburg MC, Reijnierse EM, van Wezel RJA, Meskers CGM, et al. Blood pressure drop rate after standing up is associated with frailty and number of falls in geriatric outpatients. J Am Heart Assoc. 2020;9:e014688. doi: 10.1161/JAHA.119.014688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.014688</ArticleId><ArticleId IdType="pmc">PMC7428630</ArticleId><ArticleId IdType="pubmed">32223397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Borrel D, Sabbaghan K, Kum C, Yang Y, Robinovitch SN, et al. Relationships between orthostatic hypotension, frailty, falling and mortality in elderly care home residents. BMC Geriatr. 2019;19:80. doi: 10.1186/s12877-019-1082-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1082-6</ArticleId><ArticleId IdType="pmc">PMC6415493</ArticleId><ArticleId IdType="pubmed">30866845</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;20. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81:e16&#x2013;25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire GM. Coronavirus: why men are more vulnerable to covid-19 than women? SN Compr Clin Med. 2020;2:874&#x2013;6. doi: 10.1007/s42399-020-00341-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82:378&#x2013;83. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, B &#xc1;S, Gaini S, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73:e4058&#x2013;63. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, Bierle DM, Salonen BR, Collins NM, et al. The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. 2022;97:454&#x2013;64. doi: 10.1016/j.mayocp.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garc&#xed;a B, Romay Lema E, Rabu&#xf1;al Rey R, Health Perception among Female COVID-19 Patients. Comment on Fern&#xe1;ndez-de-las-Pe&#xf1;as. et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC9181377</ArticleId><ArticleId IdType="pubmed">35683388</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: long covid risk is lower with omicron than delta, researchers find. BMJ. 2022;377:o1500. doi: 10.1136/bmj.o1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>